Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Determinants of Quality of Life Related to Health in Alzheimer Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by CHU de Reims
Sponsor:
Information provided by (Responsible Party):
CHU de Reims
ClinicalTrials.gov Identifier:
NCT01570322
First received: April 2, 2012
Last updated: June 8, 2016
Last verified: June 2016
  Purpose

Study the factors that explain Health-Related Quality of Life (HRQL) in patients with Alzheimer disease including:

  • The influence of the environment (physical and human) on Health-Related Quality of Life (HRQL),
  • The influence of non-drug and drug treatments on Health-Related Quality of Life (HRQL),
  • The influence of formal and informal help mobilized,
  • The influence of interactions "patient - caregiver" on Health-Related Quality of Life (HRQL),
  • The influence of the ratio necessary cost on available resources on Health-Related Quality of Life (HRQL)

Condition
Alzheimer Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by CHU de Reims:

Primary Outcome Measures:
  • Health-Related Quality of Life (HRQOL) Assessment

Estimated Enrollment: 400
  Eligibility

Ages Eligible for Study:   75 Years and older   (Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
  • Patients with Alzheimer disease (DSM IV - Diagnostic and Statistical Manual of Mental Disorders - and NINCDS/ADRDA - National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association)
  • Patients with MMSE (Mini Mental State Examination) > or = 10
Criteria

Inclusion Criteria:

  • Patients with Alzheimer disease (DSM IV and NINCDS-ADRDA)
  • Patients with MMSE (Mini Mental State Examination) > or = 10
  • Out patients

Exclusion Criteria:

  • Severe sensory disturbances,
  • Non French speaking
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01570322

Contacts
Contact: Jean-Luc NOVELLA, MD PhD jlnovella@chu-reims.fr

Locations
France
CHU de REIMS Recruiting
Reims, France, 51092
Contact: Jean-Luc NOVELLA, MD PhD       jlnovella@chu-reims.fr   
Sponsors and Collaborators
CHU de Reims
  More Information

Responsible Party: CHU de Reims
ClinicalTrials.gov Identifier: NCT01570322     History of Changes
Other Study ID Numbers: PN09004 
Study First Received: April 2, 2012
Last Updated: June 8, 2016
Health Authority: France: Ministry of Health

Keywords provided by CHU de Reims:
Dementia - Alzheimer - Quality of life

Additional relevant MeSH terms:
Alzheimer Disease
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Tauopathies
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders

ClinicalTrials.gov processed this record on December 07, 2016